Tonix Pharmaceuticals Holding (TNXP) EPS (Weighted Average and Diluted): 2021-2024
Historic EPS (Weighted Average and Diluted) for Tonix Pharmaceuticals Holding (TNXP) over the last 4 years, with Dec 2024 value amounting to -$176.60.
- Tonix Pharmaceuticals Holding's EPS (Weighted Average and Diluted) rose 84.17% to -$3.59 in Q3 2025 from the same period last year, while for Sep 2025 it was $279.28, marking a year-over-year increase of 101.64%. This contributed to the annual value of -$176.60 for FY2024, which is 98.80% up from last year.
- Latest data reveals that Tonix Pharmaceuticals Holding reported EPS (Weighted Average and Diluted) of -$176.60 as of FY2024, which was up 98.80% from -$14,720 recorded in FY2023.
- In the past 5 years, Tonix Pharmaceuticals Holding's EPS (Weighted Average and Diluted) registered a high of -$8.10 during FY2021, and its lowest value of -$14,720 during FY2023.
- For the 3-year period, Tonix Pharmaceuticals Holding's EPS (Weighted Average and Diluted) averaged around -$4,972, with its median value being -$176.60 (2024).
- Per our database at Business Quant, Tonix Pharmaceuticals Holding's EPS (Weighted Average and Diluted) tumbled by 73,464.47% in 2023 and then surged by 98.80% in 2024.
- Over the past 4 years, Tonix Pharmaceuticals Holding's EPS (Weighted Average and Diluted) (Yearly) stood at -$8.10 in 2021, then plummeted by 147.04% to -$20.01 in 2022, then crashed by 73,464.47% to -$14,720 in 2023, then spiked by 98.80% to -$176.60 in 2024.